Enfortumab vedotin Interactions
There are 482 drugs known to interact with enfortumab vedotin, along with 3 disease interactions. Of the total drug interactions, 76 are major, 357 are moderate, and 49 are minor.
- View all 482 medications that may interact with enfortumab vedotin
- View enfortumab vedotin disease interactions (3)
Most frequently checked interactions
View interaction reports for enfortumab vedotin and the medicines listed below.
- Aspir 81 (aspirin)
- Benadryl (diphenhydramine)
- Benefiber Powder (wheat dextrin)
- Bystolic (nebivolol)
- Calcium 600+D Plus Minerals (multivitamin with minerals)
- Colace (docusate)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- D3 (cholecalciferol)
- Dulcolax Stool Softener (docusate)
- Eliquis (apixaban)
- Farxiga (dapagliflozin)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Lyrica (pregabalin)
- Maxzide (hydrochlorothiazide / triamterene)
- Medrol Dosepak (methylprednisolone)
- Metamucil Orange Smooth Texture Sugar Free (psyllium)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Mucinex (guaifenesin)
- Myrbetriq (mirabegron)
- One Tab Daily (multivitamin)
- OxyContin (oxycodone)
- Protonix (pantoprazole)
- Senokot (senna)
- Tylenol (acetaminophen)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Enfortumab vedotin disease interactions
There are 3 disease interactions with enfortumab vedotin which include:
Report options
More about enfortumab vedotin
- enfortumab vedotin consumer information
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
Mitomycin
Mitomycin is used for anal cancer, bladder cancer, pancreatic cancer, stomach cancer, urothelial ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
